Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
5
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
startups
deals
europe blog main
europe top stories
fda
gilead sciences
ipo
pfizer
takeda pharmaceutical
venture capital
abbvie
What
bio
roundup
new
acquisitions
ceo
covid
daniel
drug
gilead
ipo
medicines
o’day
sciences
activity
advantages
announced
approvals
bails
bar
biggest
biogen
brand
bridgebio
brings
build
buy
capital
car
clamped
collabs
company’s
deal
debut
delays
develop
developing
drugs
dyne’s
economic
emerges
Language
unset
5
×
Current search:
biotech
×
novartis
×
cancer
×
unset
×
" san diego top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone